Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent De...(Total assets ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
Date:11/9/2009
Total assets $267,345 $241,331 ======== ======== Liabilities and Stockholders' Equity Accounts payable and accrued liabilities $16,893 $46,789 Total deferred revenues 4,049 4,049 Derivative liabilities 11,715 - Notes payable 52,974 8,567 Total lease financing obligations & other long-term liabilities 79,154 64,294 Total stockholders' equity 102,560 117,632 ------- ------- Total liabilities & stockholders' equity $267,345 $241,331 ======== ======== Note: The Condensed Consolidated Balance Sheet Data has been derived from the audited financial statements as of that date.
Contact: Arena Pharmaceuticals, Inc. Media Contact: Russo Partners
Jack Lief David Schull, President
President and CEO david.schull@russopartnersllc.com
858.717.2310
Cindy McGee
Manager, IR and Corporate Communications Anthony J. Russo, Ph.D., CEO
858.453.7200, ext. 1479 tony.russo@russopartnersllc.com
212.845.4251
www.arenapharm.com
SOURCE Arena Pharmaceuticals, Inc.
'/>"/>
| SOURCE Arena Pharmaceuticals, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
Post Your Comments:
(Date:11/25/2009)... COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--Re...ream-likefoamthatstopsseverebleeding,wonfirstprize...theGlobalSecurityChallenge2009,companyofficialsann...omaroundtheworld,Remedium,steampitchedtheirinventi...choolofBusiness. ,, Remedium( www.remediumtechn...
(Date:11/25/2009)... BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosc...fantithromboticaptamerswithactivecontrolagents,ann...sentingatthePiperJaffray21stAnnualHealthCareConfer...spresentationwillbegivenat1:10pm(EST)onTuesday,Dec...newithemphasisontheleaddevelopmentprogram,theantic...
(Date:11/25/2009)... NEWYORK,Nov.25/PRNewswire/--Reportlinker.comannou...talogue: ,, UnitedStatesDentalDevicesMarketAna...inker.com/p0158733/United-States-Dental-Devices-Ma...itedStatesDentalDevicesMarketAnalysisandForecastst...lsourceforin-depthinformationanddatarelatingtotheU...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12Aprima Medical Software Inc Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51802 1Aprima Medical Software Inc Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51802 2Aprima Medical Software Inc Unveiled by iMedica 3B Premier EHR PM Company Adopts New Name 51802 3Gene Mutation Is Linked to Heart Muscle Disease 51799 1Gene Mutation Is Linked to Heart Muscle Disease 51799 2Netsmart Technologies Acquires Pharmacy Management Software Company 51795 1Netsmart Technologies Acquires Pharmacy Management Software Company 51795 2Netsmart Technologies Acquires Pharmacy Management Software Company 51795 3[0] Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam[0] Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009[0] Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015
... known as steroids, widely used to treat,inflammat...orotic fractures with up to 50% of patients o... than 800 men and women shows higher bone mineral ...rent established therapy(3) - Regulatory appr... glucocorticoid-induced osteoporosis in US,...
...s Disease Clinical Development and Focus on ..., TOKYO, April 11 E2007 (perampanel) is a first-...-competitive AMPA-type glutamate,receptor antagoni...s,including Parkinson,s disease, neuropathic pain,...axis., The AMPA receptor is widely present in alm...
Other Medicine Technology:Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids 2Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids 3Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids 4Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids 5Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids 6Status of the E2007 (perampanel) Development Program 2Status of the E2007 (perampanel) Development Program 3Status of the E2007 (perampanel) Development Program 4(Date:11/25/2009)... vaccine carried into the body on a carefully engi...uccessfully eliminate tumors in mammals, scientist...tional Medicine . , The new approach, pioneered ...rsity, uses plastic disks impregnated with tumor-s...eprogram the mammalian immune system to attack tum...
(Date:11/25/2009)...s that can occur in children with autism and relat... that includes medication combined with a structur... University researchers and their colleagues. , ...nal of the American Academy of Child and Adolescen...onal Institute of Mental Health (NIMH) Research Un...
(Date:11/25/2009)...esh that mimicked parts of speech colored percepti...lthDay News) -- People can "hear" not only with th...hows. , In fact, sensations on the skin designe... people decipher sounds better, the Canadian scien... whether we could use tactile information in this ...
(Date:11/25/2009)...iative expands to include cost-effective, sustaina...healthcare professionals in developing world. , ...mber 25, 2009 -- Elluminate, Inc. , the leader in...s that support 21st century teaching, learning, a...nd Ice initiative was awarded iNACOL,s first-eve...
(Date:11/25/2009)...wswire-FirstCall/--TheAdvisoryBoardCompany(Nasdaq:...tAnnualPiperJaffrayHealthCareConferenceinNewYorkCi...M(EST),willbetheCompany,sChiefExecutiveOfficer,Rob...cer,MichaelT.Kirshbaum.Thepresentationmaterialswil...ww.advisoryboardcompany.com ,throughDecember16,200...
Breaking Medicine News(10 mins):Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:Your Skin Can Help Your Ears Listen 2Health News:Your Skin Can Help Your Ears Listen 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5[1] Implant-based cancer vaccine is first to eliminate tumors in mice[0] Parent training key to improved treatment of behavior problems in children with autism[0] Your Skin Can Help Your Ears Listen [1] Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice[0] The Advisory Board Company to Present at 21st Annual Piper Jaffray Health Care Conference
...ses the risk of a car crash resulting in serious i...sity of Auckland studied 500 drivers and passenger...999 and 2000.// A furthe r400 drivers using the re...ous car smash, while those who reported five hours...
...o, have been assessing the effectiveness of an an...n, which is commonly prescribed for treatment of b...arbitrarily allocated 150 adults with acute bronch...ce in quality-of-life scores between the two group...
... altitudes are likely to age faster. Scientists dr...tions of hormones, which are important for maintai...he mountainous areas.
For comparison researche... hormones DHEA and DHEAS (dehydroepiandrosterone a...
...k raspberries reduces the risk of colon cancer. It...and vegetables may reduce the risk of cancer. Now ...he protective compounds that various types of prod....
Groups of rats that had been given a compo...
...aring loss are going down well with those who use ... adults aged over 60 in the United States. Traditi...ng problem - an acoustic hearing aid. //
Now,...00 adults fitted with one of the implants. They fi...
...n population, which evaluated more than 14,000 spe...a man's sperm, reducing their numbers as well as t... most significant finding was that as the ozone le... Southern California's Keck School of Medicine.// ...
Other Medicine News:Health News:High Altitude ‘Speeds up ageing process 2Health News:Elevated Ozone Levels Hurt Sperm Count 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |